Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
IGENE BIOTECHNO (IGNE) had Return on Equity of 13.22% for the most recently reported fiscal quarter, ending 2010-09-30.
| Income Statement Financials | |
-- |
|
$-0.62M |
|
-- |
|
-- |
|
$0.66M |
|
$-0.66M |
|
$0.04M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.66M |
|
$-0.62M |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.44M |
|
-- |
|
$0.21M |
|
$3.41M |
|
$2.13M |
|
$0.36M |
|
$5.96M |
|
$8.09M |
|
$-4.69M |
|
$-4.89M |
|
$-4.68M |
|
-- |
|
| Cash Flow Statement Financials | |
$-1.01M |
|
$-0.01M |
|
$0.00M |
|
$1.29M |
|
$0.26M |
|
$-1.02M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.15 |
|
-- |
|
-- |
|
-0.08 |
|
-0.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.02M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
13.22% |
12.68% |
|
-18.18% |
|
14.35% |
|
-- |
|
-- |
|
-- |
|